Status:
COMPLETED
Ocular Manifestations of Inflammatory Bowel Disease
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Inflammatory Bowel Diseases
Ophthalmopathy
Eligibility:
All Genders
18+ years
Brief Summary
Ocular damage is found in the 3rd rank of extra intestinal manifestations (MEI) Potentially serious functional complications (see uveitis and risk of blindness) requiring rapid management Rare uveitis...
Eligibility Criteria
Inclusion
- Adult patients followed at Nancy University Hospital for IBD and having consulted in the ophthalmology department
Exclusion
- Minor patients
- patients without IBD
- patients for whom there is no ophthalmology consultation
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2020
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT04771039
Start Date
January 1 2013
End Date
December 12 2020
Last Update
February 25 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.